Abstract:Objective:To investigate the clinical characteristics and prognosis of patients with dilated cardiomyopathy(DCM). Method:Clinical data of 280 patients with DCM and follow-up outcomes of 187 patients(66.8%)were analyzed. Result:All the patients, 221 cases(78.9%)of male and 59(21.1%)of female, were aged 48.0±14.2 years at diagnosis. NYHA classification Ⅰ~Ⅱ was found in 60 patients(21.4%)and Ⅲ in 155(55.4%), Ⅳ in 65(23.2%) respectively. Eight patients were familial DCM with younger age of onset than that of sporadic ones([35.4±11.4] vs [48.4±14.1], P<0.01). Arrhythmias were observed in 253 patients(90.4%), including 71(25.4%) with atrial fibrillation, 90(32.1%)with polymorphic ventricular premature beats,130(46.4%)with paroxysmal ventricular tachycardia , 64(22.9%)with left bundle branch block. Most patients showed enlargement of left or all cardiac chambers in echocardiography. Larger left ventricular end-diastolic diameter(68.9±8.4 mm vs 63.8±7.8 mm) and lower left ventricular ejection fraction([31.8±10.1]% vs [41.8%±12.0]%)were found in patients with NYHA Ⅲ~Ⅳ than in those withⅠ~Ⅱ(P<0.01). Medical treatments included angiotensin converting enzyme inhibitors in 199 patients(70.1%)and beta-blockers in 168 pts (60.0%). One hundred and eighty-seven patients(66.8%)were followed up for (29.8±23.2) months. Fifty patients died during follow-up, including 27 patients(54.0%)died of heart failure and 20(40.0%)of sudden death. Seven patients underwent heart transplantation.The transplant free survial rates at 1, 2 and 5 years were 93.4%, 86.0% and 65.3% respectively. The 5 year survial rate in the 8 index patients with familial DCM was lower than that of sporadic ones(40.0% vs 68.5%, P<0.05).Conclusion:Most patients with DCM manifested heart failure of NYHA Ⅲ~Ⅳ with complex arrhythmias and enlargement of cardiac chambers when diagnosed. The 2 and 5 years survival rates werehigher than those had been reported at home before, which indicated the clinical improvement in DCM. However,heart failure and sudden death are still main causes of mortality. Patients with familial DCM are often with relatively younger age at onset and worse prognosis than sporadic ones.

Clinical analysis of 280 patients with dilated cardiomyopathy